Background: In differentiated human monocyte-derived macrophages (MDM), HIV-1 assembles primarily on intracellular plasma membrane (PM) connected compartments (IPMC). It is unclear how the IPMC differs from the cell surface PM, or whether the IPMC is indeed the only site for virus assembly in MDM. As the endosomal sorting complex required for transport (ESCRT) machinery is required for the final scission events that release assembled virus from the PM, we inhibited ESCRT-mediated scission of HIV-1 in macrophages to generate stable budding intermediates in order to identify the main site(s) where virus is assembled in MDM. Methodology: We used siRNA to deplete expression of the ESCRT pathway proteins Tsg101 and ALIX, or we generated HIV-1 mutants defective in ESCRT recruitment. Cells were either infected with virus or nucleofected with provirus. Virus release was characterised by western blotting, and the distribution of virus was analysed by immunofluorescence (IF). Electron microscopy (EM) was used to identify HIV-1 budding sites. Results: In siRNA experiments, good knockdown efficiencies were achieved for ALIX and Tsg101, but effects on virus release were only modest, perhaps because many of the infected cells had escaped the knockdown. To address these complications, we mutated motifs in Gag p6 required for recruitment of Tsg101 (PTAP−) and ALIX (YP−), or deleted the entire p6 (Δp6). In MDM, the release of PTAP− and Δp6 viruses was inhibited more efficiently and to the same extent for both mutants, compared to the YP− mutant (63% vs. 29%). This showed that, as in other cells, Tsg101 is more important than ALIX for virus release in MDM. To analyse the global distribution of virus in the cells, we used IF. In a significant number of cells, both the WT and the PTAP− mutant viruses were found to assemble only at the IPMC (Fig 1). To verify these findings, we performed EM on MDM infected with PTAP− mutant viruses. Consistent with the IF data, we observed immature HIV-1 budding profiles mainly associated with the IPMC. Conclusions: Our study is the first to provide conclusive evidence that the IPMC is the preferred assembly site for HIV-1 in MDM. Because macrophages are long-lived compared to T-cells, this “archiving” of HIV in the IPMC may conceal it from immune surveillance, which may have implications for HIV therapy and disease progression.